CD81-Positive Exosomes: These exosomes carry EGFR variants instrumental in tracking resistance to targeted therapies in non-small cell lung cancer (NSCLC), enabling timely adjustments in treatment strategies [101,102]. This evidence concerns the gene CD81 and non-small cell lung carcinoma.